Furthermore, within a few weeks, Deangeli was the winner of the MRC Dtp Grant of the School of Clinical Medicine and of the Darwin College Studentship of the British university. To these are added the Hevolus Innovation Scholarship, awarded by the homonymous company, an Italian partner of Microsoft and strongly committed to talent scouting – and the Ermenegildo Zegna Founder’s Scholarship: the scholarship that selects and supports the highest Italian excellence who wish to maintain contact with our country, to make a contribution to its cultural and scientific growth.
“Giulio Deangeli is a boy out of the ordinary in many respects, the human one above all – commented the rector of the University of Pisa, Paolo Mancarella – His results stem from a precious talent combined with an innate leadership ability that is allowing him to emerge internationally. I am proud that our university has been able to enhance it and make it grow, giving us a young researcher who will certainly make a significant contribution to the development of our country. In a delicate moment like the one we are experiencing, it is reassuring to know that the future of Italy is in the hands of children like him “.Giulio Deangeli is far from a brain on the run. In all these years, he has been a very active protagonist in the Italian academic and social fabric, carrying out innumerable projects not only of research, but also of volunteering and scientific dissemination. And it does not intend to stop in this mission.
“My love for science has always been visceral – says Deangeli – but I must thank the extraordinarily stimulating academic environment in which I found myself in Pisa if today my most ambitious projects are materializing. I have a deep feeling of gratitude towards my university and my country, for putting me in the best conditions to pursue my dreams “. First of all, the possibility of conducting a research project in the field of neuroscience and, more specifically, of neurodegenerative diseases, with the PhD in Clinical Neurosciences at the University of Cambridge, for which he was recently selected. “Neurodegenerations constitute a social and scientific problem of colossal proportions – explains Deangeli -. I have no doubt about the choice to dedicate my life to making my contribution to fight this tragedy”.
The PhD in Cambridge will allow him to work in the world gotha of neurodegeneration research, alongside the Professor Maria Grazia Spillantini, Fellow of the Royal Society and discoverer of alpha-synuclein (the central protein of Parkinson’s) as well as scientific heir of the Nobel Prize Rita Levi-Montalcini. His co-supervisor will be Professor Michel Goedert, awarded the Brain Prize in 2018 (the Nobel Prize in Neuroscience), Fellow of the Royal Society, probably the world’s leading expert on tau protein (the central protein of Alzheimer’s). “This is an opportunity of immense scientific depth – explains Deangeli – both for the immeasurable caliber of the two teachers who will follow me, and for the repertoire of ultra-advanced techniques to which I will have access, such as CryoEm, Super- Resolution Microscopy and Clem, in which Cambridge is the spearhead worldwide. ”
The University of Cambridge receives 22,000 applications per year for postgraduate courses. The highly prestigious Vice Chancellor’s Award / Cambridge International Scholarship is awarded for academic and research merits to the best 250 candidates across the university, regardless of nationality. In the case of Deangeli, this award will be further supported by a co-financing from the exclusive Darwin College, thus making it an even more selective “double-scholarship”, an acknowledgment that on average is given to only one student each year.
In addition, the prestigious Mrc Dtp Research Grant, awarded by the School of Clinical Medicine of the University of Cambridge, which Deangeli obtained without even having to apply. A more unique than rare case that makes him the only student with three official scholarships from the Cantabrian university. A record, this, which adds to a long list of successes of this boy, who landed in 2014 at the University of Pisa, where he ranked first in the admission test to Medicine. He was always first in the national competition for access to the Sant’Anna School of Advanced Studies. As a first he arrived in 2016 at the European Amgen Scholars Symposium of the University of Cambridge and, in 2018, at the Harvard iGem Biohackathon of the University of Harvard.
This, after having won, in 2013, the Neuroscience Olympics, the Italian phase of the International Brain Bee – Ibb: an international competition that tests students of second grade secondary schools on the level of knowledge in the field of Neuroscience and where Giulio Deangeli , ranked second runner-up in the world, is still the only Italian to be on the world podium in the twenty years of history of this prestigious competition. Just as it is still the only Italian awarded the Harvard Hip Scholarship, the only official Harvard research scholarship open to international students.
His extraordinary talent has not gone unnoticed by the commissions of the two other important scholarships that Giulio Deangeli has won. The first was conferred by Hevolus Innovation, Italian technological excellence and official partner of Microsoft, as well as one of the 7 companies in the world engaged in the development of futuristic Mixed Reality solutions with Microsoft HoloLens. Established to support innovative research projects in multidisciplinary contexts, the Hevolus Innovation Scholarship aims to select and encourage young talents by promoting their scientific training courses and professional growth.
The other is the Ermenegildo Zegna Founder’s Scholarship. A scholarship created to allow a small number of exceptionally promising Italians to undertake a post-graduate research or specialization abroad and given primarily to those who, like Giulio Deangeli, have the potential to become leaders in their sector and are animated by a sincere interest in fighting brain drain by promoting and maintaining academic contacts and social commitment in our country.